Frontiers of high-throughput metabolomics

•Metabolomics enables rapid measurements at 10–100 times higher throughput than proteomics.•The achievable throughput opens entirely new scientific and medical opportunities.•Key limitations are study design and data analyses to generate testable molecular hypotheses. Large scale metabolomics studie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in chemical biology 2017-02, Vol.36, p.15-23
Hauptverfasser: Zampieri, Mattia, Sekar, Karthik, Zamboni, Nicola, Sauer, Uwe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 23
container_issue
container_start_page 15
container_title Current opinion in chemical biology
container_volume 36
creator Zampieri, Mattia
Sekar, Karthik
Zamboni, Nicola
Sauer, Uwe
description •Metabolomics enables rapid measurements at 10–100 times higher throughput than proteomics.•The achievable throughput opens entirely new scientific and medical opportunities.•Key limitations are study design and data analyses to generate testable molecular hypotheses. Large scale metabolomics studies are increasingly used to investigate genetically different individuals and time-dependent responses to environmental stimuli. New mass spectrometric approaches with at least an order of magnitude more rapid analysis of small molecules within the cell's metabolome are now paving the way towards true high-throughput metabolomics, opening new opportunities in systems biology, functional genomics, drug discovery, and personalized medicine. Here we discuss the impact and advantages of the progress made in profiling large cohorts and dynamic systems with high temporal resolution and automated sampling. In both areas, high-throughput metabolomics is gaining traction because it can generate hypotheses on molecular mechanisms and metabolic regulation. We conclude with the current status of the less mature single cell analyses where high-throughput analytics will be indispensable to resolve metabolic heterogeneity in populations and compartmentalization of metabolites.
doi_str_mv 10.1016/j.cbpa.2016.12.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1856866598</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1367593116301909</els_id><sourcerecordid>1856866598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e4411fc37dcaec46e97fe88979cb7d8e719156101fce6faea27a0e1b6a7f3fee3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwBxhQRxgSbCfxh8SCKgpIlVhgthzn3LhK6mInSPx7XLUwMt0Nz_vq7kHomuCcYMLuN7mpdzqnac8JzTFmJ2hKBJcZLjE9TXvBeFbJgkzQRYwbnAgqqnM0oQKzEgs5RXfL4LeDgxDn3s5bt26zoQ1-XLe7cZj3MOjad753Jl6iM6u7CFfHOUMfy6f3xUu2ent-XTyuMlNUbMigLAmxpuCN0WBKBpJbEEJyaWreCOBEkoql-60BZjVoyjUGUjPNbWEBihm6PfTugv8cIQ6qd9FA1-kt-DEqIiomGKukSCg9oCb4GANYtQuu1-FbEaz2itRG7RWpvSJFqEoCUujm2D_WPTR_kV8nCXg4AJC-_EpqVDQOtgYaF8AMqvHuv_4fitR3ug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1856866598</pqid></control><display><type>article</type><title>Frontiers of high-throughput metabolomics</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Zampieri, Mattia ; Sekar, Karthik ; Zamboni, Nicola ; Sauer, Uwe</creator><creatorcontrib>Zampieri, Mattia ; Sekar, Karthik ; Zamboni, Nicola ; Sauer, Uwe</creatorcontrib><description>•Metabolomics enables rapid measurements at 10–100 times higher throughput than proteomics.•The achievable throughput opens entirely new scientific and medical opportunities.•Key limitations are study design and data analyses to generate testable molecular hypotheses. Large scale metabolomics studies are increasingly used to investigate genetically different individuals and time-dependent responses to environmental stimuli. New mass spectrometric approaches with at least an order of magnitude more rapid analysis of small molecules within the cell's metabolome are now paving the way towards true high-throughput metabolomics, opening new opportunities in systems biology, functional genomics, drug discovery, and personalized medicine. Here we discuss the impact and advantages of the progress made in profiling large cohorts and dynamic systems with high temporal resolution and automated sampling. In both areas, high-throughput metabolomics is gaining traction because it can generate hypotheses on molecular mechanisms and metabolic regulation. We conclude with the current status of the less mature single cell analyses where high-throughput analytics will be indispensable to resolve metabolic heterogeneity in populations and compartmentalization of metabolites.</description><identifier>ISSN: 1367-5931</identifier><identifier>EISSN: 1879-0402</identifier><identifier>DOI: 10.1016/j.cbpa.2016.12.006</identifier><identifier>PMID: 28064089</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Drug Discovery ; High-Throughput Screening Assays - methods ; Humans ; Mass Spectrometry - methods ; Metabolome ; Metabolomics - methods ; Plants ; Precision Medicine ; Systems Biology - methods</subject><ispartof>Current opinion in chemical biology, 2017-02, Vol.36, p.15-23</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e4411fc37dcaec46e97fe88979cb7d8e719156101fce6faea27a0e1b6a7f3fee3</citedby><cites>FETCH-LOGICAL-c356t-e4411fc37dcaec46e97fe88979cb7d8e719156101fce6faea27a0e1b6a7f3fee3</cites><orcidid>0000-0002-5923-0770 ; 0000-0003-2045-9364</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1367593116301909$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28064089$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zampieri, Mattia</creatorcontrib><creatorcontrib>Sekar, Karthik</creatorcontrib><creatorcontrib>Zamboni, Nicola</creatorcontrib><creatorcontrib>Sauer, Uwe</creatorcontrib><title>Frontiers of high-throughput metabolomics</title><title>Current opinion in chemical biology</title><addtitle>Curr Opin Chem Biol</addtitle><description>•Metabolomics enables rapid measurements at 10–100 times higher throughput than proteomics.•The achievable throughput opens entirely new scientific and medical opportunities.•Key limitations are study design and data analyses to generate testable molecular hypotheses. Large scale metabolomics studies are increasingly used to investigate genetically different individuals and time-dependent responses to environmental stimuli. New mass spectrometric approaches with at least an order of magnitude more rapid analysis of small molecules within the cell's metabolome are now paving the way towards true high-throughput metabolomics, opening new opportunities in systems biology, functional genomics, drug discovery, and personalized medicine. Here we discuss the impact and advantages of the progress made in profiling large cohorts and dynamic systems with high temporal resolution and automated sampling. In both areas, high-throughput metabolomics is gaining traction because it can generate hypotheses on molecular mechanisms and metabolic regulation. We conclude with the current status of the less mature single cell analyses where high-throughput analytics will be indispensable to resolve metabolic heterogeneity in populations and compartmentalization of metabolites.</description><subject>Animals</subject><subject>Drug Discovery</subject><subject>High-Throughput Screening Assays - methods</subject><subject>Humans</subject><subject>Mass Spectrometry - methods</subject><subject>Metabolome</subject><subject>Metabolomics - methods</subject><subject>Plants</subject><subject>Precision Medicine</subject><subject>Systems Biology - methods</subject><issn>1367-5931</issn><issn>1879-0402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqXwBxhQRxgSbCfxh8SCKgpIlVhgthzn3LhK6mInSPx7XLUwMt0Nz_vq7kHomuCcYMLuN7mpdzqnac8JzTFmJ2hKBJcZLjE9TXvBeFbJgkzQRYwbnAgqqnM0oQKzEgs5RXfL4LeDgxDn3s5bt26zoQ1-XLe7cZj3MOjad753Jl6iM6u7CFfHOUMfy6f3xUu2ent-XTyuMlNUbMigLAmxpuCN0WBKBpJbEEJyaWreCOBEkoql-60BZjVoyjUGUjPNbWEBihm6PfTugv8cIQ6qd9FA1-kt-DEqIiomGKukSCg9oCb4GANYtQuu1-FbEaz2itRG7RWpvSJFqEoCUujm2D_WPTR_kV8nCXg4AJC-_EpqVDQOtgYaF8AMqvHuv_4fitR3ug</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Zampieri, Mattia</creator><creator>Sekar, Karthik</creator><creator>Zamboni, Nicola</creator><creator>Sauer, Uwe</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5923-0770</orcidid><orcidid>https://orcid.org/0000-0003-2045-9364</orcidid></search><sort><creationdate>201702</creationdate><title>Frontiers of high-throughput metabolomics</title><author>Zampieri, Mattia ; Sekar, Karthik ; Zamboni, Nicola ; Sauer, Uwe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e4411fc37dcaec46e97fe88979cb7d8e719156101fce6faea27a0e1b6a7f3fee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Drug Discovery</topic><topic>High-Throughput Screening Assays - methods</topic><topic>Humans</topic><topic>Mass Spectrometry - methods</topic><topic>Metabolome</topic><topic>Metabolomics - methods</topic><topic>Plants</topic><topic>Precision Medicine</topic><topic>Systems Biology - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zampieri, Mattia</creatorcontrib><creatorcontrib>Sekar, Karthik</creatorcontrib><creatorcontrib>Zamboni, Nicola</creatorcontrib><creatorcontrib>Sauer, Uwe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in chemical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zampieri, Mattia</au><au>Sekar, Karthik</au><au>Zamboni, Nicola</au><au>Sauer, Uwe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frontiers of high-throughput metabolomics</atitle><jtitle>Current opinion in chemical biology</jtitle><addtitle>Curr Opin Chem Biol</addtitle><date>2017-02</date><risdate>2017</risdate><volume>36</volume><spage>15</spage><epage>23</epage><pages>15-23</pages><issn>1367-5931</issn><eissn>1879-0402</eissn><abstract>•Metabolomics enables rapid measurements at 10–100 times higher throughput than proteomics.•The achievable throughput opens entirely new scientific and medical opportunities.•Key limitations are study design and data analyses to generate testable molecular hypotheses. Large scale metabolomics studies are increasingly used to investigate genetically different individuals and time-dependent responses to environmental stimuli. New mass spectrometric approaches with at least an order of magnitude more rapid analysis of small molecules within the cell's metabolome are now paving the way towards true high-throughput metabolomics, opening new opportunities in systems biology, functional genomics, drug discovery, and personalized medicine. Here we discuss the impact and advantages of the progress made in profiling large cohorts and dynamic systems with high temporal resolution and automated sampling. In both areas, high-throughput metabolomics is gaining traction because it can generate hypotheses on molecular mechanisms and metabolic regulation. We conclude with the current status of the less mature single cell analyses where high-throughput analytics will be indispensable to resolve metabolic heterogeneity in populations and compartmentalization of metabolites.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28064089</pmid><doi>10.1016/j.cbpa.2016.12.006</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-5923-0770</orcidid><orcidid>https://orcid.org/0000-0003-2045-9364</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1367-5931
ispartof Current opinion in chemical biology, 2017-02, Vol.36, p.15-23
issn 1367-5931
1879-0402
language eng
recordid cdi_proquest_miscellaneous_1856866598
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Drug Discovery
High-Throughput Screening Assays - methods
Humans
Mass Spectrometry - methods
Metabolome
Metabolomics - methods
Plants
Precision Medicine
Systems Biology - methods
title Frontiers of high-throughput metabolomics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T19%3A17%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frontiers%20of%20high-throughput%20metabolomics&rft.jtitle=Current%20opinion%20in%20chemical%20biology&rft.au=Zampieri,%20Mattia&rft.date=2017-02&rft.volume=36&rft.spage=15&rft.epage=23&rft.pages=15-23&rft.issn=1367-5931&rft.eissn=1879-0402&rft_id=info:doi/10.1016/j.cbpa.2016.12.006&rft_dat=%3Cproquest_cross%3E1856866598%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1856866598&rft_id=info:pmid/28064089&rft_els_id=S1367593116301909&rfr_iscdi=true